Biomaterial-engineered Intra-articular Drug Delivery Systems for Osteoarthritis Therapy

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2019 Sep 17

PMID 31524006

Citations 41

Authors

Longfa Kou

Shuyi Xiao

Rui Sun

Shihui Bao

Qing Yao

Ruijie Chen

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis (OA) is a progressive and degenerative disease, which is no longer confined to the elderly. So far, current treatments are limited to symptom relief, and no valid OA disease-modifying drugs are available. Additionally, OA relative joint is challenging for drug delivery, since the drugs experience rapid clearance in joint, showing a poor bioavailability. Existing therapeutic drugs, like non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, are not conducive for long-term use due to adverse effects. Though supplementations, including chondroitin sulfate and glucosamine, have shown beneficial effects on joint tissues in OA, their therapeutic use is still debatable. New emerging agents, like Kartogenin (KGN) and Interleukin-1 receptor antagonist (IL-1 ra), without a proper formulation, still will not work. Therefore, it is urgent to establish a suitable and efficient drug delivery system for OA therapy. In this review, we pay attention to various types of drug delivery systems and potential therapeutic drugs that may escalate OA treatments.

Citing Articles

Polysaccharide-based hydrogels for cartilage regeneration.

Chen N, Li S, Miao C, Zhao Q, Dong J, Li L Front Cell Dev Biol. 2024; 12:1444358.

PMID: 39463764 PMC: 11503028. DOI: 10.3389/fcell.2024.1444358.

New insights into the mechanisms and therapeutic strategies of chondrocyte autophagy in osteoarthritis.

Tang L, Ding J, Yang K, Zong Z, Wu R, Li H J Mol Med (Berl). 2024; 102(10):1229-1244.

PMID: 39145815 DOI: 10.1007/s00109-024-02473-1.

Functional Nanomaterials for the Treatment of Osteoarthritis.

Yi X, Leng P, Wang S, Liu L, Xie B Int J Nanomedicine. 2024; 19:6731-6756.

PMID: 38979531 PMC: 11230134. DOI: 10.2147/IJN.S465243.

Inflammation-Responsive Mesoporous Silica Nanoparticles with Synergistic Anti-inflammatory and Joint Protection Effects for Rheumatoid Arthritis Treatment.

Wu Y, Chen W, Zeng Y, Ji Q, Yang Y, Guo X Pharm Res. 2024; 41(7):1493-1505.

PMID: 38918308 DOI: 10.1007/s11095-024-03732-z.

Screening of poly-beta amino ester coated emulsion of ketorolac for cartilage delivery.

Saeedi T, Prokopovich P J Mater Chem B. 2024; 12(24):5930-5939.

PMID: 38804519 PMC: 11186506. DOI: 10.1039/d4tb00313f.

References

Johnson K, Zhu S, Tremblay M, Payette J, Wang J, Bouchez L . A stem cell-based approach to cartilage repair. Science. 2012; 336(6082):717-21. DOI: 10.1126/science.1215157. View

Kang M, Kim J, Im G . Thermoresponsive nanospheres with independent dual drug release profiles for the treatment of osteoarthritis. Acta Biomater. 2016; 39:65-78. DOI: 10.1016/j.actbio.2016.05.005. View

Choi B, Kim S, Lin B, Wu B, Lee M . Cartilaginous extracellular matrix-modified chitosan hydrogels for cartilage tissue engineering. ACS Appl Mater Interfaces. 2014; 6(22):20110-21. DOI: 10.1021/am505723k. View

Zhang X, Yu C, Xushi , Zhang C, Tang T, Dai K . Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun. 2006; 341(1):202-8. DOI: 10.1016/j.bbrc.2005.12.171. View

Lu H, Zhao H, Wang K, Lv L . Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Int J Pharm. 2011; 420(2):358-65. DOI: 10.1016/j.ijpharm.2011.08.046. View

Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H . Osteoarthritis. Lancet. 2015; 386(9991):376-87. DOI: 10.1016/S0140-6736(14)60802-3. View

Lee Y, Choi J, Kang Y, Kim H, Kim S, Park C . Triamcinolone-carbon nanotube conjugation inhibits inflammation of human arthritis synovial fibroblasts. J Mater Chem B. 2020; 4(9):1660-1671. DOI: 10.1039/c5tb01693b. View

Le Graverand M, Vignon E, Otterness I, Hart D . Early changes in lapine menisci during osteoarthritis development: Part II: molecular alterations. Osteoarthritis Cartilage. 2001; 9(1):65-72. DOI: 10.1053/joca.2000.0351. View

Larsen C, Ostergaard J, Larsen S, Jensen H, Jacobsen S, Lindegaard C . Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci. 2008; 97(11):4622-54. DOI: 10.1002/jps.21346. View

10.

McMasters J, Poh S, Lin J, Panitch A . Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model. J Control Release. 2017; 258:161-170. PMC: 5535751. DOI: 10.1016/j.jconrel.2017.05.008. View

11.

Pelletier J, Martel-Pelletier J, Rannou F, Cooper C . Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016; 45(4 Suppl):S22-7. DOI: 10.1016/j.semarthrit.2015.11.009. View

12.

Williams A, Camilleri J, Goodfellow R, Williams B . A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. Br J Rheumatol. 1996; 35(8):719-24. DOI: 10.1093/rheumatology/35.8.719. View

13.

Sulistio A, Mansfeld F, Reyes-Ortega F, DSouza A, Ng S, Birkett S . Intra-articular Treatment of Osteoarthritis with Diclofenac-Conjugated Polymer Reduces Inflammation and Pain. ACS Appl Bio Mater. 2022; 2(7):2822-2832. DOI: 10.1021/acsabm.9b00232. View

14.

Madry H, Cucchiarini M . Gene therapy for human osteoarthritis: principles and clinical translation. Expert Opin Biol Ther. 2015; 16(3):331-46. DOI: 10.1517/14712598.2016.1124084. View

15.

Bannuru R, Osani M, Vaysbrot E, Arden N, Bennell K, Bierma-Zeinstra S . OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019; 27(11):1578-1589. DOI: 10.1016/j.joca.2019.06.011. View

16.

Jain A, Mishra S, Vuddanda P, Singh S, Singh R, Singh S . Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Nanomedicine. 2014; 10(5):1031-40. DOI: 10.1016/j.nano.2014.01.008. View

17.

Bajpayee A, Scheu M, Grodzinsky A, Porter R . Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra-articular injected avidin in rat knee joints. J Orthop Res. 2014; 32(8):1044-51. DOI: 10.1002/jor.22630. View

18.

Kraus V, Conaghan P, Aazami H, Mehra P, Kivitz A, Lufkin J . Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis.... Osteoarthritis Cartilage. 2017; 26(1):34-42. DOI: 10.1016/j.joca.2017.10.003. View

19.

Navarro-Sarabia F, Coronel P, Collantes E, Navarro F, de la Serna A, Naranjo A . A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011; 70(11):1957-62. PMC: 3184238. DOI: 10.1136/ard.2011.152017. View

20.

Hayder M, Poupot M, Baron M, Nigon D, Turrin C, Caminade A . A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Transl Med. 2011; 3(81):81ra35. DOI: 10.1126/scitranslmed.3002212. View